Trademark: 79263445
Word
ALYVANT
Status
Registered
Status Code
700
Status Date
Tuesday, July 14, 2020
Serial Number
79263445
Registration Number
6098335
Registration Date
Tuesday, July 14, 2020
Mark Type
3000
Filing Date
Friday, October 12, 2018
Published for Opposition
Tuesday, April 28, 2020

Trademark Owner History
Roivant Sciences GmbH - Original Registrant

Classifications
9 Downloadable computer software for providing, analyzing and generating reports; downloadable computer software for data processing; downloadable software and downloadable computer programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; downloadable software and downloadable computer programs for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of public health, healthcare, namely, pharmaceutical commercialization, biomedical research and development and for analyzing clinical trial data; downloadable computer software for use in management of databases featuring pharmaceutical and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for obtaining and providing updated scientific, medical and clinical information, and for obtaining and providing news of general interest related to disease awareness or pharmaceutical products; downloadable computer software for accessing data and information related to healthcare services and patient medical information, and for controlling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuring, monitoring, processing and tracking health, wellness and medical information
35 Advertising services related to pharmaceutical products; business management; business administration; business research and information services; market research and provision of information regarding market research; data processing services; analysis of business data; business data and statistical analysis, documentation being compilation of statistics and professional business consultancy services regarding statistics for biomedical research, namely, related to pharmaceutical commercialization, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; business data analysis and statistical analysis of healthcare data, biomedical research and clinical trial data for business purposes to include pharmaceutical commercialization; systematization and compilation of data in computer databases; analyzing and compiling of business data and analysis of business management for medical, purposes, public health and healthcare purposes; business research, market testing being market research and statistical analysis services for business purposes in the fields of public health, healthcare and biomedicine, namely, pharmaceutical commercialization and products, and for clinical trials; business advisory services, consultancy and information; advertising, marketing and sales promotion services for the pharmaceutical and medical products of others; providing business intelligence services in the fields of pharmaceuticals, public health and healthcare; providing an on-line database providing business intelligence in the fields of pharmaceuticals, public health and healthcare
41 Educational services, namely, arranging, conducting and organizing classes, seminars, conferences, symposiums and training workshops in the field of healthcare and pharmaceuticals to promote the exchange of information and resources within the scientific research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals, and distribution of training materials in connection therewith
42 Scientific and technological services, namely, research and design in the field of software for managing healthcare data; analysis of technical data by computers, being technical medical research in the field of healthcare, prescription and related data being carried out using computers; pharmaceutical and biomedical research services; research in the field of pharmaceutical, biologic therapeutic products, clinical trials, post-authorization medical research for the marketing of medicines and/or commercial post-launching of medicines and epidemiology; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines and epidemiology; providing temporary use of online non-downloadable computer software for allowing users to connect to databases containing pharmaceutical and medical information; providing temporary use of online non-downloadable computer software for management of medical practices and research in connection with or related to pharmaceutical commercialization; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientific, medical and clinical information, and for obtaining and providing news of general interest; providing temporary use of online non-downloadable computer software for accessing data and information related to healthcare services and patient medical information, and for controlling and managing data and information related to healthcare services and patient medical information
44 Providing health and medical information to potential customers of pharmaceutical products; providing internet-based healthcare information in support of potential commercialization of pharmaceutical products for the treatment of diseases, disorders or conditions; providing health and medical information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biologic products for the prevention and treatment of diseases, disorders and conditions; medical services, namely, providing medical services and consultation related to pharmaceutical products or disease awareness over the telephone and via the Internet through the use of personal computers, smartphones, tablets, mobile and wireless devices, and other telecommunication devices; pharmaceutical advice; medical and pharmaceutical consultation related to pharmaceutical products or disease awareness; medical assistance services in the nature of the provision of medical information, namely, information related to pharmaceutical products or disease awareness provided to medical professionals and potential patients from remote locations via the Internet and global computer networks through the use of a data storage and retrieval system
Color is not claimed as a feature of the mark.
The mark consists of the wording ''ALYVANT'' to the right of an interconnected circle design and additional circle design.
The word(s) "ALYVANT" has no meaning in a foreign language.

Trademark Events
Nov 28, 2020
Final Decision Transaction Processed By Ib
Nov 6, 2020
Final Disposition Notice Sent To Ib
Nov 6, 2020
Final Disposition Processed
Oct 14, 2020
Final Disposition Notice Created, To Be Sent To Ib
Jul 14, 2020
Registered-Principal Register
Apr 28, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 28, 2020
Published For Opposition
Apr 8, 2020
Notification Of Notice Of Publication E-Mailed
Mar 25, 2020
Approved For Pub - Principal Register
Mar 12, 2020
Teas/Email Correspondence Entered
Mar 12, 2020
Correspondence Received In Law Office
Mar 12, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 11, 2020
Assigned To Lie
Mar 5, 2020
Teas Response To Office Action Received
Dec 13, 2019
New Representative At Ib Received
Nov 6, 2019
Attorney Review Completed
Nov 1, 2019
Correction From Ib Entered - Attorney Review Required
Sep 20, 2019
Refusal Processed By Ib
Sep 19, 2019
Correction Transaction Received From Ib
Sep 9, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 9, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 5, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Sep 5, 2019
Refusal Processed By Mpu
Aug 22, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Aug 21, 2019
Non-Final Action Written
Aug 20, 2019
Application Filing Receipt Mailed
Aug 16, 2019
Assigned To Examiner
Aug 16, 2019
New Application Office Supplied Data Entered In Tram
Jul 31, 2019
Limitation From Original Application Entered
Jul 18, 2019
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24